Micah Mitchell Sells 90,231 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Micah Mitchell sold 90,231 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $0.86, for a total transaction of $77,598.66. Following the completion of the sale, the insider owned 109,478 shares in the company, valued at $94,151.08. This represents a 45.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Myomo Trading Up 2.5%

MYO opened at $0.91 on Friday. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.93. Myomo, Inc. has a fifty-two week low of $0.61 and a fifty-two week high of $3.69. The firm has a market capitalization of $35.17 million, a PE ratio of -2.53 and a beta of 1.39. The company’s 50-day moving average is $0.76 and its 200 day moving average is $0.85.

Analyst Upgrades and Downgrades

Separately, Craig Hallum restated a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $7.67.

Institutional Investors Weigh In On Myomo

Several institutional investors and hedge funds have recently added to or reduced their stakes in MYO. Rosalind Advisors Inc. increased its stake in Myomo by 33.0% in the 2nd quarter. Rosalind Advisors Inc. now owns 3,595,788 shares of the company’s stock valued at $7,767,000 after buying an additional 892,127 shares during the last quarter. Jefferies Financial Group Inc. purchased a new stake in Myomo in the 4th quarter valued at about $641,000. Geode Capital Management LLC increased its stake in Myomo by 160.8% in the 2nd quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock valued at $1,446,000 after buying an additional 412,631 shares during the last quarter. Centiva Capital LP purchased a new stake in Myomo in the 3rd quarter valued at about $190,000. Finally, Prescott Group Capital Management L.L.C. purchased a new stake in Myomo in the 4th quarter valued at about $169,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.